IP Library Granted Patent US 9,284,354
Granted Patent B2
US 9,284,354 · App. 14/007,211 · Granted Mar 15, 2016

Immunoglobulin-binding polypeptide

Inventors: Shinichi Yoshida (Takasago, JP); Dai Murata (Takasago, JP); Shunichi Taira (Takasago, JP)
Assignee: Kaneka Corporation
C07K14/00C07K14/31C07K14/47
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,284,354
App. No.
14/007,211
Granted
Mar 15, 2016
Kind
B2
Abstract

An object of the present invention is to provide novel polypeptides that are capable of binding to an immunoglobulin and have high stability against alkali. The present invention relates to proteins having the amino acid sequence of SEQ ID No:1 or 2.

Claims (51)

1. A polypeptide, that binds to a protein comprising an Fc region of an immunoglobulin, the polypeptide comprising the following amino acid sequence:

(SEQ ID NO: 47)

RFX 1 X 2 EQQNAFYEILHX 3 PNLTEEQRNX 4 FIQX 5 LX 6 X 7 X 8 PSVSREX 9 L

AEAX 10 X 11 LNDAQAPX 12

wherein X 1 is D, E, N, or Q;

X 2 is E or R;

X 3 is L, M, or I;

X 4 is A, E, F, R, Y, or W;

X 5 is D, E, H, I, L, Q, R, S, T, or V;

X 6 is H, I, or R;

X 7 is D, I, or R;

X 8 is D or E;

X 9 is I, L, or V;

X 10 is R or Q;

X 11 is H or R; and

X 12 is R, G, or K.

2. A polypeptide, that binds to a protein comprising an Fc region of an immunoglobulin, the polypeptide comprising the following amino acid sequence:

(SEQ ID NO: 48)

Z 1 Z 2 Z 3 RFX 1 X 2 EQQNAFYEILHX 3 PNLTEEQRNX 4 FIQX 5 LX 6 X 7 X 8 PSVS

REX 9 LAEAX 10 X 11 LNDAQAPX 12

wherein X 1 is D, E, N, or Q;

X 2 is E or R;

X 3 is L, M, or I;

X 4 is A, E, F, R, Y, or W;

X 5 is D, E, H, I, L, Q, R, S, T, or V;

X 6 is H, I, or R;

X 7 is D, I, or R;

X 8 is D or E;

X 9 is I, L, or V;

X 10 is R or Q;

X 11 is H or R;

X 12 is R, G, or K; and

Z 1 to Z 3 are each independently A, D, E, G, H, I, L, N, Q, R, S, T, V, or Y.

3. The polypeptide according to claim 1 ,

which has at least 90% sequence identity to one of the following amino acid sequences:

(SEQ ID No: 1)

ADNRFNREQQNAFYEILHLPNLTEEQRNAFIQSLRDDPSVSREILAEAR

RLNDAQAPG

and

(SEQ ID No: 2)

ADNRFNREQQNAFYEILHLPNLTEEQRNAFIQSLRDDPSVSREILAEAR

RLNDAQAPR.

4. The polypeptide according to claim 2 ,

which has at least 90% sequence identity to one of the following amino acid sequences:

(SEQ ID No: 1)

ADNRFNREQQNAFYEILHLPNLTEEQRNAFIQSLRDDPSVSREILAEAR

RLNDAQAPG

and

(SEQ ID No: 2)

ADNRFNREQQNAFYEILHLPNLTEEQRNAFIQSLRDDPSVSREILAEAR

RLNDAQAPR.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2014
From: YOSHIDA, SHINICHI; MURATA, DAI; TAIRA, SHUNICHI
To: KANEKA CORPORATION
Reel/Frame 032064/0604 →
Priority Claims (1)
JP 2011-068497 · Mar 25, 2011 · national
Continuity (1)
Related Publication 20140100356A1 · Apr 10, 2014